Fear of dementia is rising almost as fast as the condition itself. And where fear grows, so does a market promising protection. Among the most popular offerings is Ginkgo biloba, a centuries-old ...

A study has shown that there are different health outcomes for Black adults in the U.S. who attended Historically Black ...

Cognition Therapeutics (NASDAQ:CGTX) used its fourth-quarter and full-year 2025 earnings call to outline a shift in ...

Amid an influx of new drugs targeting one of the believed root causes of Alzheimer’s disease, a new symptomatic med has hit the scene, courtesy of Vancouver’s Alpha Cognition. On Monday, the FDA gave ...

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found no evidence that the transitional symptoms of menopause such as brain fog and memory ...

A research team from Fraunhofer HNFIZ has published a newly developed evaluation model that classifies the technical ...

Backed by $200 million in funding, 28-year-old Scott Wu and his team of competitive coders at Cognition are building an AI tool that can program entirely on its own, like an “army of junior engineers.

Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.51 per share a year ago. These ...